FAM
BDSX icon

Fred Alger Management’s Biodesix BDSX Stock Holding History

Fred Alger Management’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-6,545
Closed -$215K – 522
2022
Q2 		$215K Sell
6,545
-131
-2% -$4.26K ﹤0.01% 424
2022
Q1 		$226K Sell
6,676
-39
-0.6% -$2.55K ﹤0.01% 436
2021
Q4 		$710K Sell
6,715
-248
-4% -$32.4K ﹤0.01% 419
2021
Q3 		$1.15M Buy
6,963
+101
+1% +$19.2K ﹤0.01% 378
2021
Q2 		$1.81M Sell
6,862
-93
-1% -$29.2K ﹤0.01% 355
2021
Q1 		$2.83M Sell
6,955
-92
-1% -$41.1K 0.01% 328
2020
Q4 		$2.84M Buy
+7,047
New +$2.19M 0.01% 312

Other funds holding BDSX

BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fred Alger Management's BDSX Position: Q3 2022 in Review

Fred Alger Management sold out of Biodesix (BDSX) in Q3 2022, closing a stake of 6,545 shares — an estimated $215K sold.

Fred Alger Management first reported a position in BDSX in Q4 2020 and held it in 7 quarters. The position peaked at $2.84M in Q4 2020. 27 funds tracked by Wall St. Rank hold BDSX as of Q3 2022.

  • Fred Alger Management reported no remaining Biodesix position as of Q3 2022 after selling out during the quarter.
  • Fred Alger Management sold 6,545 Biodesix shares in Q3 2022, an estimated $215K.
  • Fred Alger Management first reported a position in Biodesix in Q4 2020 and held it in 7 quarters.
  • Fred Alger Management's Biodesix position peaked at $2.84M in Q4 2020.
  • 27 funds tracked by Wall St. Rank held Biodesix as of Q3 2022.

Based on Fred Alger Management's 13F filing for Q3 2022, filed 15 Nov 2022.